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1. Introduction 
Since the first report by Morgan and Austin [l] , 
a number of papers dealing with the in vitro incorpo- 
ration of labeled precursors into macromolecules of 
isolated synaptosomes and mitochondria have 
appeared in the literature [ 2- 1.51. Although there 
is generally good agreement among workers in this 
field regarding the existence of a peripheral protein 
synthesizing system, apparently independent of the 
perikaryal one, the evidence has at times been some- 
what ambiguous and contradictory, particularly 
with respect to the behaviour of the system in the 
presence of inhibitors of protein synthesis. Accord- 
ingly we have attempted to re-examine the problem, 
using highly purified whole synaptosomes and syn- 
aptosomal membranes isolated by a new procedure. 
The results, together with those of other workers 
[ 1 l] , suggest hat nerve endings contain at least 
two different structures capable of autonomous 
protein synthesis: the mitochondria and the mem- 
branes. Both synaptosomal sub-fractions as well as 
the whole synaptosome appear to incorporate radio- 
active amino acids in a chloramphenicol-sensitive 
and cycloheximide-resistant manner. 
2. Materials and methods 
Synaptosomes and sub-synaptosomal struc- 
tures were prepared, from rat brain, by a modifica- 
tion of the method of Kornguth et al. [ 161, which 
reduces the entire procedure to 24 hr without 
sacrificing purity. This procedure is described in 
detail elsewhere [ 171 , For illustrative purposes, 
some contamination values are given in table 1. 
Incubation media for the different structures, 
together with other experimental details, are de- 
scribed in the legends to figures and tables. 
In all cases the incubation was stopped by addi- 
tion of an equal volume of 10% trichloroacetic 
acid containing 10 mM leucine. The precipitate 
was dissolved in 4 ml of 0.5 N NaOH, kept for 30 
min at 45”, and reprecipitated with 1 ml of 4 N 
trichloroacetic acid. After the pellets were washed 
with 3 ml of 10% trichloroacetic acid, they were 
suspended in 3 ml of ethanol/ether (1: 1) and in- 
cubated at 45” for 30 min. After a final washing 
with 3 ml of ethanol/ether (1: 3), the pellets were 
dried and dissolved in 1 ml of 1 N NaOH. Aliquots 
were taken for radioactivity assay in a toluene-based 
scintillant, containing Triton X-100 (85% efficiency 
for 14C), and for protein measurement by the method 
ofLowryetal. [18]. 
Extreme care was taken to avoid bacterial conta- 
mination. All the glassware and instruments were 
autoclaved, and the solutions were either autoclaved 
or filtered through 0.45 pm Millipore filters into 
sterile containers immediately prior to use. Actual 
contamination was checked by plating 0.1 ml ali- 
quots of the incubated material onto blood-agar plates, 
just before the end of the incubation. 
3. Results and discussion 
Our results are displayed in fig. 1 and table 2. 
Values presented are actual results of one experiment 
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Table 1 
Contamination of synaptosomal membranes by different 
structures. 
Mitochondria 
Endoplasmic reticulum 
Myelin 
Axonal membranes 
Glial membranes 
2-5% 
3-4% 
< 2% 
< 3% 
2-3% 
The level of contamination was estimated by assay for 
appropriate marker enzymes, or by a radioassay described 
in detail elsewhere [ 171 
with duplicate samples. More than 6 experiments were 
carried out under the same conditions with the var- 
iation in results, from experiment to experiment, 
not exceeding 10% for a given set of conditions. 
The time course of incorporation of “C-leucine 
into isolated synaptosomal,membranes, in vitro, is 
illustrated in fig. 1. It can be seen that the incorpo- 
ration is virtually linear for at least 30 min under the 
conditions used. It is worthy of note that, although 
the amount of leucine incorporated is rather low 
(0.42 picomoles/mg of membranes/hr, when using 
1 pCi/ml of “C-leucine), the incorporation approxi- 
mately doubles when the amount of precursor avail- 
able is doubled, indicating that the system is far from 
saturated. The lower synthetic capacity, in compari- 
son with other preparations described in the literature, 
may simply be due to the fact that we are dealing 
with highly purified synaptosomes and synaptosomal 
membranes, and have eliminated incorporation due 
to contaminants. Nevertheless the possibility of 
some damage to the biological material -after 24 hr 
of manipulation, including one step of purification 
through a gradient of cesium chloride, cannot be ex- 
cluded. 
The effects of some protein synthesis inhibitors 
on the incorporation of leucine into synaptosomal 
membranes and synaptosomes are shown in table 2. 
It can be seen that the membrane incorporation is 
not affected by cycloheximide or RNase, but is 
virtually completely inhibited by chloramphenicol. 
Similarly the incorporation into whole synaptosomes 
is sensitive to chloramphenicol and completely re- 
sistant to cycloheximide. These data may be con- 
trasted with the results of other workers, who have 
found [ l-3,7,9, 121 that up to 70% or more of 
synaptosomal protein synthesis is inhibited by cyclo- 
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Fig. 1. Time course of “C-leucine (U) incorporation into 
isolated synaptosomal membranes, in vitro. The incubation 
was carried out in a 50 ml Erlenmeyer flask containing 10 ml 
of the following medium: 50 mM Tris-HCl, pH 7.4; 125 mM 
NaCl; 25 mM KCl; 10 mM MgCla; 2 mM ATP; 5’mM phos- 
phoenolpyruvate; 50 pg/ml of pyruvate kinase; and 2 pCi/mL 
of 14C-leucine (U) (The Radiochemical Centre, Amersham, 
specific activity 344 mCi/mmole). Membrane concentration 
in this medium was about 2 mg/ml. The incubation was 
carried out at 37” in a shaking water bath. Aliquots of 0.5 ml 
were taken, in duplicate, at the times shown in the figure, 
and processed as described under Materials and methods. 
heximide, with only O-30% being chloramphenicol- 
sensitive. It is important to note that, in the latter 
studies, the synaptosomal preparations used were 
of questionable purity. In general the material has 
been prepared by the original methods of Gray and 
Whittaker [ 191 and De Robertis et al. [20], with 
some modifications. Although a quantitative estimate 
of the contamination by other fractions is not usually 
available, we have found [ 171 that mitochondria 
and endoplasmic reticulum are present in the latter 
preparations to a far greater extent than in our own 
(see table 1). In addition, Cotman and Taylor [lo] 
have performed autoradiography of synaptosomal 
preparations, following incubation with tritiated 
amino acids, and have found that only 48% of the 
grains are localized over synaptosomes. Similar re- 
sults were obtained by Gambetti et al. [ 151 . Accord- 
ingly it seems likely that the cycloheximide sensitivity 
observed in earlier studies on synaptosomal protein 
synthesis could be due to contamination by 80 S ri- 
bosome-containing vesicles, as has been suggested by 
Morgan [6]. Heavily labeled vesicles of this kind were 
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Table 2 
Incorporation of 14C-leucine (U) into isolated synaptosomal membranes, synaptosomal mitochondria and 
whole synaptosomes, in vifro. Effect of some protein synthesis inhibitors. 
Additions Specific activity 
(cpm/mg/hr) 
a) Synaptosomal membranes 
None 269 
Chloramphenicol, 100 kg/ml 28 
Cycloheximide, 200 fig/ml 290 
Chloramphenicol + cycloheximide 26 
(same concentrations) 
RNase, 100 fig/ml 250 
% 
of control 
100 
10.4 
108 
9.1 
93 
b) Synaptosomal mitochondria 
None 915 
c) Whole synaptosomes 
None 330 100 
Chloramphenicol, 100 gg/ml 31 11.2 
Cycloheximide, 200 &/ml 321 99 
Incubations were carried out in 10 ml Erlenmeyer flasks containin? 2 mg of material in 1 ml of the medium described in the 
legend to fig. 1. The concentration of radioactive leucine was 1 kll/rnl. The incubation was stopped after 60 min at 37” and 
specific activity values calculated as described. 
identified by Cotman and Taylor in their autoradio- 
graphic study [IO]. In addition, an elegant study by 
_!!ernandez et al. [ 1 I] has shown that contamination 
of mitochondrial preparations by 80 S ribosome- 
containing vesicles was the origin of the anomalous 
sensitivity of brain “ mitochondria” to cyclohexi- 
mide [2, 5,7,9]. 
In view of the characteristics of the system, it 
was of critical importance to determine the contri- 
bution to the incorporation into membranes by 
contaminating mitochondria and bacteria. The 
synthetic capacity of synaptosomal mitochondria 
under the present conditions is 3.4 times that of 
membranes (table 2). Therefore a contamination 
level of 30% would be required to explain all the 
incorporation into membranes in terms of con- 
taminating mitochondria. With respect to bacteria, 
blood-agar plates, containing an aliquot of the in- 
cubated material, did not show any visible colonies 
after 24 hr at 37”. After 72 hr it was possible to 
count from 50 to 500 small colonies per mg of 
incubated material (either synaptosomal mem- 
branes or whole synaptosomes). These differences 
between samples with respect to bacterial content 
were not accompanied by any differences in the 
specific radioactivity. 
Furthermore when E. coli cells, growing in the 
exponential phase, were added to autoclaved mem- 
branes deprived of synthetic capacity and the mix- 
ture was incubated by the standard procedure, it 
was necessary to add more than 5,000 bacteria per 
mg of membranes to get “specific activity” values 
comparable to those routinely observed. In addi- 
tion, these fresh E. coli gave, after only 24 hr of 
incubation in blood-agar plates, round colonies up 
to 3 mm in diameter. 
As an additional control, rat optic nerve and tract 
axonal membranes, free of synaptic endings, were 
isolated and purified by the same procedure and 
subsequently incubated under the same conditions 
as in standard experiments. No incorporation of 
radioactive precursor was observed although the level 
of bacterial and mitochondrial contamination was 
the same as in the synaptosomal membranes. 
Weiss has suggested [2 1 ] that the disintegration 
of transported mitochondria, upon arrival at the 
nerve ending, could provide the material responsible 
for protein synthesis in isolated synaptosomes. 
Although our results are consistent with this hypo- 
thesis, it is unlikely that mitoribosomal material, 
by simply sticking to the membranes during the 
19 
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isolation procedure, could account for the remark- 
able reproducibility of our specific activity values. 
Nevertheless such a system may be a means of 
supplying RNA to the synaptic membranes to aid 
in the development and maintenance of interneu- 
ronal connections. 
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